Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol pretreatment

Journal of Neural Transmission
P Kaur, S Ahlenius

Abstract

The present experiments were undertaken in order to examine mechanisms of action for reported interactions between the beta-blocker (-)-pindolol and serotonergic agents. It was found that pretreatment with (-)-pindolol (2 mg kg-1 s.c.) potentiated the stereotyped forward locomotion induced by the 5-HT2A/C receptor agonist DOI (0.125-1.0 mg kg-1 s.c.) in rats observed in an open-field arena. This (-)-pindolol/DOI-induced stereotyped forward locomotion was fully antagonized by the 5-HT2A/C receptor antagonist ritanserin (2 mg kg-1 s.c.), suggesting that (-)-pindolol enhances serotonin release, resulting i.a. in postsynaptic 5-HT2A/C receptor activation. This effect by (-)-pindolol is in all probability indirect since this compound lacks affinity for 5-HT2A/C receptors, and could be explained by reported antagonism of inhibitory serotonergic somato-dendritic 5-HT1A autoreceptors, although other possibilities related to 5-HT1B receptors or beta-adrenoceptors can not be excluded at this time. Furthermore, (-)-pindolol treatment also enhanced 5-HTP-induced (12.5-100 mg kg-1 i.p.) effects on spontaneous motor activity. These effects, however, were of smaller magnitude, and less consistent than those seen in combination with DOI.

References

Aug 1, 1990·Pharmacology, Biochemistry, and Behavior·N A DarmaniR A Glennon
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·R A Glennon
Nov 1, 1985·Neuropharmacology·S Hjorth, A Carlsson
Oct 27, 1972·Brain Research·L K NgI J Kopin
Dec 1, 1984·Neuropharmacology·A R Green
Jul 1, 1995·Trends in Pharmacological Sciences·J J Lucas, R Hen
Jan 16, 1995·The Journal of Comparative Neurology·D E WrightL Jennes

❮ Previous
Next ❯

Citations

Sep 6, 2000·Pharmacology, Biochemistry, and Behavior·T KoskinenJ Sirviö
Jan 25, 2003·Pharmacology, Biochemistry, and Behavior·Phillip J SeibellDennis E Rhoads
Jun 29, 2002·Nuclear Medicine and Biology·Yolanda Zea-PonceMarc Laruelle
Dec 2, 2000·Journal of Medicinal Chemistry·J B BlairD E Nichols

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.